Questionable advertising of psychotropic medications and disease mongering.

Questionable advertising of psychotropic medications and disease mongering.

Bibliographic Details
Main Authors:	Jeffrey R Lacasse, Jonathan Leo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2006-07-01
Series:	PLoS Medicine
Online Access:	http://europepmc.org/articles/PMC1518694?pdf=render

Similar Items

Confessions of a disease monger.
by: James Phelps
Published: (2006-07-01)

Disease Mongering in Neurological Disorders
by: Silvia Kochen, et al.
Published: (2013-12-01)

Disease mongering: one of the hidden consequences.
by: Kenneth Gillman
Published: (2006-07-01)

Disease mongering in psychiatry: fact or fiction?
by: S Saddichha
Published: (2010-12-01)

Awareness and attitudes about disease mongering among medical and pharmaceutical students.
by: C Jairaj Kumar, et al.
Published: (2006-04-01)

The newest mania: seeing disease mongering everywhere.
by: S Nassir Ghaemi
Published: (2006-07-01)

Combating disease mongering: daunting but nonetheless essential.
by: Iona Heath
Published: (2006-04-01)

The fight against disease mongering: generating knowledge for action.
by: Ray Moynihan, et al.
Published: (2006-04-01)

Disease mongering is now part of the global health debate.
by: Ray Moynihan, et al.
Published: (2008-05-01)

Fairness creams in South Asia--a case of disease mongering?
by: P Ravi Shankar, et al.
Published: (2006-07-01)

Serotonin and depression: a disconnect between the advertisements and the scientific literature.
by: Jeffrey R Lacasse, et al.
Published: (2005-12-01)

Female sexual dysfunction: a case study of disease mongering and activist resistance.
by: Leonore Tiefer
Published: (2006-04-01)

Disease mongering in drug promotion: do governments have a regulatory role?
by: Barbara Mintzes
Published: (2006-04-01)

Makers and mongers: Exploring social networks of Vermont artisan cheese
by: DiStefano, Rachel Anne
Published: (2014)

Psychotropic medication use among patients with celiac disease
by: Haley M. Zylberberg, et al.
Published: (2018-03-01)

A “cadeia alimentar” no mercado da saúde: do disease mongering ao doctor shopping
by: José Agostinho Santos
Published: (2013-12-01)

Cómo medicalizar la vida diaria: la creación de enfermedades o “disease mongering”
by: Ana María Vara
Published: (2008-11-01)

Educational Reform and the Reformers: Beware the Charlatans, Demagogues, Profit-Mongers, and Worse
by: Duncan WAITE
Published: (2015-12-01)

“The Looming, Crazy Stalker Coronavirus”: Fear Mongering, Fake News, and the Diffusion of Distrust
by: Alexandrea J. Ravenelle, et al.
Published: (2021-06-01)

Ghostwriting at elite academic medical centers in the United States.
by: Jeffrey R Lacasse, et al.
Published: (2010-02-01)

THE IMPACT OF PSYCHOTROPE MEDICATION ON ORAL HEALTH
by: Ilinca Untu, et al.
Published: (2020-04-01)

Meaning-Making and Rumour-Mongering in the Shadow of Terrorism: The Case of the Charlie Hebdo Attack in Paris
by: Petra Pelletier, et al.
Published: (2019-10-01)

Limitations and Problems of Current Studies in Terrorism: from Fear-mongers towards Global Justice
by: Maximiliano Korstanje
Published: (2015-09-01)

Older Adults with Alzheimer’s Disease, Comorbid Arthritis and Prescription of Psychotropic Medications
by: Judith E Balfour, et al.
Published: (2003-01-01)

Effect of Psychotropic Medications on Hammertoe Reconstruction Outcomes
by: Samuel D. Maidman BA, et al.
Published: (2020-08-01)

ECG changes in patients on chronic psychotropic medication
by: M Y H Moosa, et al.
Published: (2006-09-01)

'The purse-proud title-page monger' : representations of London booksellers and the social world of print, 1730-1760
by: Chenkin, Jennifer
Published: (2012)

Chronic use of psychotropic medications in breastfeeding women: Is it safe?
by: Nirit Kronenfeld, et al.
Published: (2018-01-01)

Parental attitudes toward the prescription of psychotropic medications for their children
by: Fatima A Al-Haidar
Published: (2008-01-01)

Using new technologies for improving psychotropic medication adherence
by: Giorgos Iniatis, et al.
Published: (2015-10-01)

Psychotropic medication consumption and work: are health professionals at risk?
by: Sarah Catherine Pole-Baker Maggioli Gouveia
Published: (2021)

Breaking Down Barriers: Increasing Access to Psychotropic Medications
by: Rice, Judy A.
Published: (2018)

Questioning the causal link between maternal smoking during pregnancy and offspring use of psychotropic medication: a sibling design analysis.
by: Lovisa Söderström, et al.
Published: (2013-01-01)

Hyponatremia and psychotropics
by: Swapnajeet Sahoo, et al.
Published: (2016-01-01)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
by: Edward C. Lauterbach, et al.
Published: (2012-01-01)

Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
by: Edward C. Lauterbach
Published: (2013-11-01)

La metamorfosis de la salud: invención de enfermedades y estrategias de comunicación Health metamorphosis: disease mongering and communication strategies
by: María Teresa Ruiz-Cantero, et al.
Published: (2011-06-01)

Estrategias de promoción del síndrome por déficit de testosterona: un caso paradigmático de invención de enfermedad (disease mongering)
by: Enrique Gavilán, et al.
Published: (2014-03-01)

Mortality and Prevalence of Falls, and their Association with Psychiatric Diagnoses and Psychotropic Medications
by: Nantawat Sitdhiraksa, et al.
Published: (2020-05-01)

Dissociative states in borderline personality disorder and their relationships to psychotropic medication
by: Pec O, et al.
Published: (2018-11-01)